Kovack Advisors, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1728321
FT. LAUDERDALE, FL
Position in REGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$244,427
-$328,099 QoQ
Shares Held
392
-47.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#995
of 1,329 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $5,014,818 across 13 Biotechnology names. REGN ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZVRA |
Zevra Therapeutics, Inc.
|
171,151 | $2,454,305 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,315 | $653,199 | |
| 3 | MRNA |
Moderna, Inc.
|
3,995 | $279,769 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,675 | $273,714 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
4,936 | $269,209 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
392 | $244,427 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
921 | $221,933 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
20,808 | $182,174 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244,427 | 392 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $572,526 | 741 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $386,706 | 501 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $215,349 | 383 | Shares | Sole | 2025-11-10 | |
| 2025-03-31 | $211,198 | 333 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $229,370 | 322 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $338,499 | 322 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $348,941 | 332 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $319,546 | 332 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $291,592 | 332 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $275,691 | 335 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $236,399 | 329 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $312,234 | 380 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $234,484 | 325 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $230,771 | 335 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $670,341 | 1,134 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,155,885 | 1,655 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $867,076 | 1,373 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $896,271 | 1,481 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $220,623 | 395 | Shares | Sole | 2021-07-29 | |
| 2020-06-30 | $227,632 | 365 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||